TCL Archive Varmus calls NIH Structure “Cumbersome,” Suggests Streamlining Based On science August 6, 1999
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
